Expert Opinion on Investigational Drugs
-
Publication Venue For
- WT1 vaccination in acute myeloid leukemia: new methods of implementing adoptive immunotherapy.. 23:417-426. 2014
- Rho-kinase inhibitors offer a new approach in the treatment of glaucoma.. 23:81-95. 2014
- Lonafarnib for cancer and progeria.. 21:1043-1055. 2012
- Is there a palliative benefit of gemcitabine plus fluoropyrimidines in patients with refractory colorectal cancer? A review of the literature previously presented: poster at the 2008 Gastrointestinal Cancer Symposium (Abstract No. 512).. 18:1257-1264. 2009
- Tolvaptan: a selective vasopressin type 2 receptor antagonist in congestive heart failure. 15:533-540. 2006
- Gut peptides in the treatment of diabetes mellitus.. 13:177-188. 2004
- Neuroinflammatory mechanisms in Alzheimer's disease: New opportunities for drug discovery. 5:449-455. 1996
- Section review: Cardiovascular & renal: Novel antiplatelet agents: The glycoprotein IIb/IIIa inhibitors. 4:1033-1044. 1995
- Early versus delayed zidovudine in the management of HIV infection. 3:809-819. 1994
- Section review pulmonary-allergy, dermatological, gastrointestinal and arthritis: Development of drugs that suppress macrophages: Beginning of a new era?. 3:699-708. 1994